Versum Ditches Entegris For Sweetened $5.8B Merck Deal
Versum on Monday abandoned its planned merger with fellow specialty chemicals company Entegris in favor of a $5.8 billion cash bid from Merck KGaA, after the interloper offered up more cash...To view the full article, register now.
Already a subscriber? Click here to view full article